Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer
Authors
Keywords
5-Fluorouracil, Bazedoxifene, IL-6/GP130, Signaling pathway, Colon cancer
Journal
APOPTOSIS
Volume 23, Issue 5-6, Pages 356-374
Publisher
Springer Nature
Online
2018-05-18
DOI
10.1007/s10495-018-1460-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-6 roles – Molecular pathway and clinical implication in pancreatic cancer – A systemic review
- (2017) Vlad-Vasile Pop et al. IMMUNOLOGY LETTERS
- Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice
- (2017) Pan Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Platelets stimulate liver sinusoidal endothelial cells to secrete interleukin-6 during the early phase of liver regeneration in mice
- (2017) J.J. Meyer et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of bazedoxifene in postmenopausal Latino women with osteoporosis
- (2017) Jose A. Hernández Bueno et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer
- (2017) Jun Zeng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
- (2017) Boyun Kim et al. Cancer Research and Treatment
- Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy
- (2017) Hui Xiao et al. PLoS One
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- CE/BZA effects on bone and quality of life in European postmenopausal women: a pooled analysis
- (2016) P. Hadji et al. CLIMACTERIC
- Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways
- (2016) Yue Gao et al. JOURNAL OF PINEAL RESEARCH
- Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
- (2016) X. Wu et al. MOLECULAR CANCER THERAPEUTICS
- Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
- (2016) Risa Kagan et al. Therapeutics and Clinical Risk Management
- Interleukin-6 trans-signaling increases the expression of carcinoembryonic antigen-related cell adhesion molecules 5 and 6 in colorectal cancer cells
- (2015) Reinhild Holmer et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD90+stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer
- (2015) Phuong T. Huynh et al. INTERNATIONAL JOURNAL OF CANCER
- A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis
- (2015) Santiago Palacios et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Drug Design Targeting Protein–Protein Interactions (PPIs) Using Multiple Ligand Simultaneous Docking (MLSD) and Drug Repositioning: Discovery of Raloxifene and Bazedoxifene as Novel Inhibitors of IL-6/GP130 Interface
- (2014) Huameng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer
- (2014) MINGDI ZHANG et al. Molecular Medicine Reports
- Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression
- (2014) Rickard Linnskog et al. Molecular Oncology
- Bazedoxifene Exhibits Antiestrogenic Activity in Animal Models of Tamoxifen-Resistant Breast Cancer: Implications for Treatment of Advanced Disease
- (2013) S. E. Wardell et al. CLINICAL CANCER RESEARCH
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
- (2011) Markus F. Neurath et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor and Cyclin D1
- (2011) J. S. Lewis-Wambi et al. MOLECULAR PHARMACOLOGY
- Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
- (2010) Kazuhito Sasaki et al. BMC CANCER
- Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner
- (2008) Adam W. Studebaker et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More